Start Date: Feb 11, 2009
End Date: Feb 10, 2014
Sarcopenia, the age-associated loss in skeletal muscle mass, is a contributing factor to the observed declines in physiological capacity and functional performance with advancing age. The economic impact of sarcopenia has been estimated at $18.5 billion, annually. The overall theme of this project will be to use a platform-based approach in the identification, evaluation, and understanding of nutritional and physical activity interventions that possess anabolic properties in skeletal muscle and have the potential to prevent or reverse impaired motor performance and/or physical dysfunction in older individuals. Using our well characterized rodent model of human sarcopenia, we propose to examine the mechanisms and efficacy of nutrient modulation on overload-induced skeletal muscle hypertrophy. We then propose to perform parallel clinical studies to examine the influence of physical activity/exercise and nutrition on the control of muscle protein turnover in older adults with defined low muscle mass and functional limitations. We will also evaluate the chronic effects of dietary protein/amino acids and physical activity/inactivity on changes in skeletal muscle structure and function and physical functioning in at risk older adults. Finally, we will examine the effects of a multi-modal physical activity program on changes in muscle mass, strength, physical functioning, and disability in older individuals with clinically demonstrated functional limitations. The unique pairing of clinical studies examining the influence of protein nutrition and physical activity on sarcopenia with basic approaches that identify the molecular landscape and potential targets in skeletal muscle for preventive interventions (nutritional, physical activity) may accelerate our ability to translate these findings to aging people.